The smell of hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
The smell of hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
Electronic nose (e-nose) devices may be used to identify volatile organic compounds (VOCs) in exhaled breath. VOCs generated via metabolic processes are candidate biomarkers of (patho)physiological pathways. We explored the feasibility of using an e-nose to generate human "breathprints" at high altitude. Furthermore, we explored the hypothesis that pathophysiological processes involved in the development of acute mountain sickness (AMS) would manifest as altered VOC profiles. Breath analysis was performed on Sherpa and lowlander trekkers at high altitude (3500 m). The Lake Louise Scoring (LLS) system was used to diagnose AMS. Raw data were reduced by principal component (PC) analysis (PCA). Cross validated linear discriminant analysis (CV-LDA) and receiver-operating characteristic area under curve (ROC-AUC) assessed discriminative function. Breathprints suitable for analysis were obtained from 58% (37/64) of samples. PCA showed significant differences between breathprints from participants with, and without, AMS; CV-LDA showed correct classification of 83.8%, ROC-AUC 0.86; PC 1 correlated with AMS severity. There were significant differences between breathprints of participants who remained AMS negative and those whom later developed AMS (CV-LDA 68.8%, ROC-AUC 0.76). PCA demonstrated discrimination between Sherpas and lowlanders (CV-LDA 89.2%, ROC-AUC 0.936). This study demonstrated the feasibility of breath analysis for VOCs using an e-nose at high altitude. Furthermore, it provided proof-of-concept data supporting e-nose utility as an objective tool in the prediction and diagnosis of AMS. E-nose technology may have substantial utility both in altitude medicine and under other circumstances where (mal)adaptation to hypoxia may be important (e.g., critically ill patients).
1-9
Lacey, Jonathan R.N.
f7ad2961-1071-47c2-9d62-42aed526bde0
Kidel, Carlos
c84675c5-9b6e-4633-89f0-92a5b8a00741
van der Kaaij, Jildou M.
81da1cb5-bf56-4e44-8cb5-5d2e2c6d2896
Brinkman, Paul
62ed409d-297d-465a-b165-6c5c05ea04b2
Gilbert-Kawai, Edward T.
2d1f0dd7-023f-4313-b513-0a1705daa71a
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Mythen, Michael G.
940f5be7-e5bc-4a90-94aa-09fdc658caad
Martin, Daniel S.
3e441b48-9221-4308-8ae6-49cbde20753f
Xtreme Everest 2 Research Group
September 2018
Lacey, Jonathan R.N.
f7ad2961-1071-47c2-9d62-42aed526bde0
Kidel, Carlos
c84675c5-9b6e-4633-89f0-92a5b8a00741
van der Kaaij, Jildou M.
81da1cb5-bf56-4e44-8cb5-5d2e2c6d2896
Brinkman, Paul
62ed409d-297d-465a-b165-6c5c05ea04b2
Gilbert-Kawai, Edward T.
2d1f0dd7-023f-4313-b513-0a1705daa71a
Grocott, Michael P.W.
1e87b741-513e-4a22-be13-0f7bb344e8c2
Mythen, Michael G.
940f5be7-e5bc-4a90-94aa-09fdc658caad
Martin, Daniel S.
3e441b48-9221-4308-8ae6-49cbde20753f
Lacey, Jonathan R.N., Kidel, Carlos, van der Kaaij, Jildou M., Brinkman, Paul, Gilbert-Kawai, Edward T., Grocott, Michael P.W., Mythen, Michael G. and Martin, Daniel S.
,
Xtreme Everest 2 Research Group
(2018)
The smell of hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness.
Physiological Reports, 6 (17), , [e13854].
(doi:10.14814/phy2.13854).
Abstract
Electronic nose (e-nose) devices may be used to identify volatile organic compounds (VOCs) in exhaled breath. VOCs generated via metabolic processes are candidate biomarkers of (patho)physiological pathways. We explored the feasibility of using an e-nose to generate human "breathprints" at high altitude. Furthermore, we explored the hypothesis that pathophysiological processes involved in the development of acute mountain sickness (AMS) would manifest as altered VOC profiles. Breath analysis was performed on Sherpa and lowlander trekkers at high altitude (3500 m). The Lake Louise Scoring (LLS) system was used to diagnose AMS. Raw data were reduced by principal component (PC) analysis (PCA). Cross validated linear discriminant analysis (CV-LDA) and receiver-operating characteristic area under curve (ROC-AUC) assessed discriminative function. Breathprints suitable for analysis were obtained from 58% (37/64) of samples. PCA showed significant differences between breathprints from participants with, and without, AMS; CV-LDA showed correct classification of 83.8%, ROC-AUC 0.86; PC 1 correlated with AMS severity. There were significant differences between breathprints of participants who remained AMS negative and those whom later developed AMS (CV-LDA 68.8%, ROC-AUC 0.76). PCA demonstrated discrimination between Sherpas and lowlanders (CV-LDA 89.2%, ROC-AUC 0.936). This study demonstrated the feasibility of breath analysis for VOCs using an e-nose at high altitude. Furthermore, it provided proof-of-concept data supporting e-nose utility as an objective tool in the prediction and diagnosis of AMS. E-nose technology may have substantial utility both in altitude medicine and under other circumstances where (mal)adaptation to hypoxia may be important (e.g., critically ill patients).
Text
Lacey et al 2018 Physiological Reports
- Version of Record
More information
Accepted/In Press date: 3 August 2018
e-pub ahead of print date: 5 September 2018
Published date: September 2018
Identifiers
Local EPrints ID: 430132
URI: http://eprints.soton.ac.uk/id/eprint/430132
PURE UUID: 603dd7b1-4483-440c-81b3-3cbada5a8a7b
Catalogue record
Date deposited: 12 Apr 2019 16:30
Last modified: 16 Mar 2024 04:00
Export record
Altmetrics
Contributors
Author:
Jonathan R.N. Lacey
Author:
Carlos Kidel
Author:
Jildou M. van der Kaaij
Author:
Paul Brinkman
Author:
Edward T. Gilbert-Kawai
Author:
Michael G. Mythen
Author:
Daniel S. Martin
Corporate Author: Xtreme Everest 2 Research Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics